Medkoo Inc.
Durham, NC Doing business as Medkoo Biosciences Medkoo Biosciences
- UEI
- RXZGEHHM4EL1
- CAGE
- 5MG17
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 2224 Sedwick Rd #102, Durham, NC 27713, USA
- Website
- medkoo.com
- Founded
- 2009
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Small molecules library for ncats ETB pre-clinical library | National Institute on Drug Abuse | $471,850 | |
| Ncats library of small molecules | National Institute on Drug Abuse | $566,895 | |
| Ncats library of small molecules. | National Institute on Drug Abuse | $0 | |
| Purchase Order HHSN271201500485P | National Institute on Drug Abuse | $7,780 |
About Medkoo Inc.
Medkoo Inc., doing business as Medkoo Biosciences, is a biochemical reagent supplier that specializes in providing small molecule drugs for lab use. The company distributes high-quality reagents to support research scientists across academic, biotechnology, biomedical, and pharmaceutical institutions. It is registered as a corporate entity for profit, and is classified as a minority-owned business and an Asian-Pacific American-owned business.
Medkoo Biosciences has been awarded multiple prime federal contracts from the National Center for Advancing Translational Sciences (NCATS) and the National Institute on Drug Abuse (NIDA), both under the National Institutes of Health (NIH). These contracts involve the provision of small molecule libraries and specific compounds for pre-clinical screening and research efforts. In 2022, NCATS awarded Medkoo a $471,850 firm fixed price purchase order for a small molecule library containing 52 specific compounds requested in the solicitation. This contract was set aside for total small businesses. In 2021, NCATS awarded Medkoo a $680,550 firm fixed price purchase order for the delivery of the NCATS Library of Small Molecules, containing 14 specific small molecule compounds with validated biological activity for high-throughput and high-content screening. NIDA also awarded Medkoo a purchase order in 2021 for the NCATS Library of Small Molecules, although the potential value was not specified. These contracts demonstrate Medkoo's expertise in providing specialized chemical compounds and libraries to support pre-clinical research programs at NIH institutes.
SBA capabilities narrative
custom synthesis of small molecular anticancer drug agents, anticancer reference substances.
Quick answers
What is Medkoo Inc.'s UEI?
Medkoo Inc.'s Unique Entity ID (UEI) in SAM.gov is RXZGEHHM4EL1.
What is Medkoo Inc.'s CAGE code?
Medkoo Inc.'s CAGE code is 5MG17.
What is Medkoo Inc.'s primary NAICS code?
Medkoo Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Medkoo Inc. located?
Medkoo Inc.'s physical address in SAM.gov is 2224 Sedwick Rd #102, Durham, NC 27713, USA.
Is Medkoo Inc. registered in SAM.gov?
Yes. Medkoo Inc.'s SAM.gov registration is active through March 17, 2027.
What is Medkoo Inc.'s most recent federal award?
Medkoo Inc.'s most recent federal contract award is Small molecules library for ncats ETB pre-clinical library (75N95022P00731), from National Institute on Drug Abuse, on September 21, 2022.
On GovTribe
See Medkoo Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors